Cargando…

The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers

15B3 is a monoclonal IgM antibody that selectively detects pathological aggregates of the prion protein (PrP). We report the unexpected finding that 15B3 also recognizes oligomeric but not monomeric forms of amyloid-β (Aβ)(42), an aggregating peptide implicated in the pathogenesis of Alzheimer’s dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stravalaci, Matteo, Tapella, Laura, Beeg, Marten, Rossi, Alessandro, Joshi, Pooja, Pizzi, Erika, Mazzanti, Michele, Balducci, Claudia, Forloni, Gianluigi, Biasini, Emiliano, Salmona, Mario, Diomede, Luisa, Chiesa, Roberto, Gobbi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044783/ https://www.ncbi.nlm.nih.gov/pubmed/27392850 http://dx.doi.org/10.3233/JAD-150882

Ejemplares similares

An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo
por: Fluharty, Brian R., et al.
Publicado: (2013)

Immunopurification of Pathological Prion Protein Aggregates
por: Biasini, Emiliano, et al.
Publicado: (2009)

Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
por: Balducci, Claudia, et al.
Publicado: (2019)

Alzheimer’s Disease, Oligomers, and Inflammation
por: Forloni, Gianluigi, et al.
Publicado: (2018)

Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?
por: Diomede, Luisa, et al.
Publicado: (2021)

Nonphosphorylated tau slows down Aβ(1–42) aggregation, binds to Aβ(1–42) oligomers, and reduces Aβ(1–42) toxicity
por: Beeg, Marten, et al.
Publicado: (2021)

The Toxicity of a Mutant Prion Protein Is Cell-Autonomous, and Can Be Suppressed by Wild-Type Prion Protein on Adjacent Cells
por: Biasini, Emiliano, et al.
Publicado: (2012)

The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection
por: De Luigi, Ada, et al.
Publicado: (2008)

Oligomeropathies, inflammation and prion protein binding
por: Forloni, Gianluigi, et al.
Publicado: (2022)

Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity()
por: Diomede, Luisa, et al.
Publicado: (2014)

Oligomers and Neurodegeneration: New Evidence
por: Forloni, Gianluigi
Publicado: (2023)

A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection
por: Beeg, Marten, et al.
Publicado: (2023)

Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation
por: Bollati, Michela, et al.
Publicado: (2022)

The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42
por: Gautieri, Alfonso, et al.
Publicado: (2019)

Cell Type-Specific Neuroprotective Activity of Untranslocated Prion Protein
por: Restelli, Elena, et al.
Publicado: (2010)

An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein
por: Stincardini, Claudia, et al.
Publicado: (2017)

Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease
por: Bouybayoune, Ihssane, et al.
Publicado: (2015)

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
por: Bate, Clive, et al.
Publicado: (2008)

Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers
por: Laurén, Juha, et al.
Publicado: (2009)

Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity
por: Diomede, Luisa, et al.
Publicado: (2021)

Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β(1-42)
por: Bate, Clive, et al.
Publicado: (2004)

Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils: IMPLICATIONS FOR CANCER
por: Ano Bom, Ana P. D., et al.
Publicado: (2012)

A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein
por: Massignan, Tania, et al.
Publicado: (2016)

A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum
por: Zeni, Luigi, et al.
Publicado: (2020)

Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons
por: Joshi, Pooja, et al.
Publicado: (2017)

Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains
por: Takahashi, Reisuke H., et al.
Publicado: (2021)

Glimepiride Reduces the Expression of PrP(C), Prevents PrP(Sc) Formation and Protects against Prion Mediated Neurotoxicity
por: Bate, Clive, et al.
Publicado: (2009)

A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation
por: Bollati, Michela, et al.
Publicado: (2021)

Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons
por: Um, Ji Won, et al.
Publicado: (2012)

Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1
por: Rushworth, Jo V., et al.
Publicado: (2013)

Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
por: Zhang, Yuan, et al.
Publicado: (2019)

A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
por: Beeg, Marten, et al.
Publicado: (2019)

Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?
por: Cerovic, Milica, et al.
Publicado: (2019)

In Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers
por: Simoneau, Steve, et al.
Publicado: (2007)

Unique Properties of the Rabbit Prion Protein Oligomer
por: Yu, Ziyao, et al.
Publicado: (2016)

Calcineurin Controls Cellular Prion Protein Expression in Mouse Astrocytes
por: Dematteis, Giulia, et al.
Publicado: (2022)

The prion-like transmission of tau oligomers via exosomes
por: Jackson, Noel A., et al.
Publicado: (2022)

Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein
por: Manassero, Giusi, et al.
Publicado: (2016)

Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy
por: König, Anna S., et al.
Publicado: (2021)

The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_teoc70828gng0j7o7p9a9g6bnr